首页> 外文期刊>Molecules >Design, Synthesis and Biological Evaluation of Novel Primaquine-Cinnamic Acid Conjugates of the Amide and Acylsemicarbazide Type
【24h】

Design, Synthesis and Biological Evaluation of Novel Primaquine-Cinnamic Acid Conjugates of the Amide and Acylsemicarbazide Type

机译:新型酰胺和酰基氨基脲化合物的伯氨喹肉桂酸缀合物的设计,合成和生物学评价

获取原文
           

摘要

In this paper design and synthesis of a scaffold comprising primaquine (PQ) motif and cinnamic acid derivatives (CADs) bound directly (compounds 3a–k) or via a spacer (compounds 7a–k) are reported. In the first series of compounds, PQ and various CADs were connected by amide bonds and in the second series by acylsemicarbazide functional groups built from the PQ amino group, CONHNH spacer and the carbonyl group originating from the CADs. PQ-CAD amides 3a–k were prepared by a simple one-step condensation reaction of PQ with a series of CAD chlorides (method A) or benzotriazolides 2 (method B). The synthesis of acylsemicarbazides 7a–k included activation of PQ with benzotriazole, preparation of PQ-semicarbazide 6 and its condensation with CAD chlorides 4. All synthesized PQ-CAD conjugates were evaluated for their anticancer, antiviral and antioxidative activities. Almost all compounds from series 3 were selective towards the MCF-7 cell line and active at micromolar concentrations. The o-fluoro derivative 3h showed high activity against HeLa, MCF-7 and in particular against the SW 620 cell line, while acylsemicarbazide 7f with a benzodioxole ring and 7c, 7g and especially 7j with methoxy-, chloro- or trifluoromethyl-substituents in the para position showed high selectivity and high inhibitory activity against MCF-7 cell line at micromolar (7c, 7f, 7g) and nanomolar (7j) levels. Acylsemicarbazide derivatives with trifluoromethyl group(s) 7i, 7j and 7k showed specific activity against human coronavirus (229E) at concentrations which did not alter the normal cell morphology. The same compounds exerted the most potent reducing activity in the DPPH test, together with 7d and 7g, while methoxy (compounds 7c–e), benzodioxole (7f), p-Cl (7g) and m-CF3 (7i) acylsemicarbazides and amide 3f presented the highest LP inhibition (83%–89%). The dimethoxy derivative 7d was the most potent LOX inhibitor (IC50 = 10 μΜ). The performed biological tests gave evidence of acylsemicarbazide functional group as superior binding group in PQ-CAD conjugates. View Full-Text
机译:在本文中,报道了包含伯氨喹(PQ)基序和肉桂酸衍生物(CAD)的支架的直接合成和合成(化合物3a–k)或通过间隔基(化合物7a–k)。在第一系列化合物中,PQ和各种CAD通过酰胺键连接,在第二系列化合物中,由PQ氨基,CONHNH间隔基和源自CAD的羰基建立的酰基半脲官能团连接。 PQ-CAD酰胺3a-k是通过PQ与一系列CAD氯化物(方法A)或苯并三唑类化合物2(方法B)的简单一步缩合反应制备的。酰基半脲7a-k的合成包括用苯并三唑活化PQ,制备PQ-半脲6和与CAD氯化物缩合4。评估了所有合成的PQ-CAD共轭物的抗癌,抗病毒和抗氧化活性。来自系列3的几乎所有化合物都对MCF-7细胞系具有选择性,并在微摩尔浓度下具有活性。邻氟衍生物3h对HeLa,MCF-7尤其是对SW 620细胞系表现出高活性,而具有苯并二恶唑环的酰基氨基脲7f和在甲氧基,氯或三氟甲基取代基中的7c,7g尤其是7j。对位显示在微摩尔(7c,7f,7g)和纳摩尔(7j)水平对MCF-7细胞系具有高选择性和高抑制活性。具有三氟甲基基团7i,7j和7k的酰基氨基脲衍生物在不改变正常细胞形态的浓度下对人冠状病毒(229E)表现出特异性活性。相同的化合物与7d和7g一起在DPPH测试中表现出最有效的还原活性,而甲氧基(化合物7c-e),苯并二恶唑(7f),对-Cl(7g)和间-CF3(7i)酰半碳酰肼和酰胺3f表现出最高的LP抑制(83%–89%)。二甲氧基衍生物7d是最有效的LOX抑制剂(IC 50 =10μM)。进行的生物学测试提供了酰基半脲官能团作为PQ-CAD偶联物中优越的结合基团的证据。查看全文

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号